Cannabis Control Commission Public Meeting
In accordance with Sections 18-25 of Chapter 30A of the Massachusetts General Laws, notice is hereby given of a meeting of the Cannabis Control Commission. The meeting will take place as noted below.
September 13, 2019
10:00AM
Location:
Massachusetts Department of Transportation
10 Park Plaza
Boston, MA 02116
Overflow meeting from September 12, if necessary.
Public Meeting Agenda:
1) Call to Order
2) Chairman’s Comments & Updates
3) Commission Discussion and Votes
a. Final Regulations
b. Expedition Policy Proposal
c. Board of Fire Prevention: Regulatory Comment
d. Research Report: A Baseline Review and Assessment of Cannabis Use and Youth Literature Review and Preliminary Data
4) Approval of Minutes
5) Executive Director’s Report
a. Job Descriptions
6) Enforcement Actions
a. MCR Laboratories, LLC (#IL281278), Independent Testing Lab
7) Staff Recommendations on Renewals
a. Patriot Care Corp. (#MCR139826), Cultivation
b. Patriot Care Corp. (#MPR243483), Product Manufacturer
c. Patriot Care Corp. (#MRR205532), Retail
d. Patriot Care Corp. (#MRR205533), Retail
e. CDX Analytics, LLC. (#ILR267888), Independent Testing Lab
f. MCR Labs, LLC. (#ILR267887), Independent Testing Lab
g. Northeast Alternatives, Inc. (#MCR139828), Cultivation
h. Northeast Alternatives, Inc. (#MPR243486), Product Manufacturer
i. Cultivate Holdings, LLC. (#MPR243485), Product Manufacturer
j. Temescal Wellness of Massachusetts, LLC. (#MRR205531), Retail
k. Temescal Wellness of Massachusetts, LLC. (#MRR205529), Retail
l. Alternative Therapies Group. (#MRR205530), Retail
m. Good Chemistry of Massachusetts, Inc. (#RMD725), Vertically Integrated Medical Marijuana Treatment Center
n. Patient Centric of Martha’s Vineyard, LTD. (#RMD1165), Vertically Integrated Medical Marijuana Treatment Center
o. Tyca Green, Inc., Vertically Integrated Medical Marijuana Treatment Center
p. The Green Harbor Dispensary, LLC. (#RMD1305), Vertically Integrated Medical Marijuana Treatment Center
q. The Green Harbor Dispensary, LLC. Vertically Integrated Medical Marijuana Treatment Center
r. Heal, Inc. Vertically Integrated Medical Marijuana Treatment Center
8) Staff Recommendations on Final Licenses
a. BeWell Organic Medicine, Inc. (#RMD1245), Vertically Integrated Medical Marijuana Treatment Center
b. Green Gold Group, Inc. (#RMD786), Vertically Integrated Medical Marijuana Treatment Center
c. Apothca, Inc. (#MR281447), Retail
d. Curaleaf Massachusetts, Inc. (#MC281309), Cultivation – Tier 11/Indoor
e. Curaleaf Massachusetts, Inc. (#MP281318), Product Manufacturer
f. Curaleaf Massachusetts, Inc. (#MR281263), Retail
g. In Good Health, Inc. (#MC281273), Cultivation – Tier 4/Indoor
h. In Good Health, Inc. (#MP281307), Product Manufacturer
i. In Good Health, Inc. (#MR282468), Retail
j. M3 Ventures, Inc. (#MC281446), Cultivation – Tier 2/Indoor
k. M3 Ventures, Inc. (#MP281346), Product Manufacturing
l. M3 Ventures, Inc. (#MR281290), Retail
9) Staff Recommendations on Provisional Licenses
a. Curaleaf Massachusetts, Inc. (#MRN282183), Retail
b. Curaleaf Massachusetts, Inc. (#MRN282052), Retail
c. HVV Massachusetts, Inc. (#MCN282121), Cultivation – Tier/Indoor
d. HVV Massachusetts, Inc. (#MPN281657), Product Manufacturing
e. HVV Massachusetts, Inc. (#MRN282578), Retail
f. The Heirloom Collective, Inc. (#MCN281438), Cultivation – Tier 2/Indoor
g. The Heirloom Collective, Inc. (#MPN281407), Product Manufacturing
10) New Business that the Chairman did not anticipate at time of posting
11) Next Meeting Date
Notice of Executive Session
Under the Open Meeting Law, G.L. c. 30A, § 21(a)(4) and (7) and the Public Records Law, G.L. c. 66, and the exemptions set forth in G.L. c. 4, § 7(26)(a), (d), (f), (g) and (n), the Commission may enter into executive session on the following agenda items:
1) to discuss provisional licensees’ qualifications for final licensure, including, but not limited to, the Commission staff’s strategies for reviewing, inspecting, and monitoring the proposed security plans of the Marijuana Establishment and for the marijuana and marijuana products.
2) to discuss operational issues, including, but not limited to, the Commission staff’s strategies for securely receiving and transferring cash deposits.
